Skip to main content
H.R. 2815 117th Congress House

BIOSIM Act

Official title: To amend title XVIII of the Social Security Act to provide for a temporary payment increase under the Medicare program for certain biosimilar biological produc… Show full official titleShow less

Official title: To amend title XVIII of the Social Security Act to provide for a temporary payment increase under the Medicare program for certain biosimilar biological products to encourage the development and use of such products.

Introduced: July 22, 2021 See on congress.gov
Health Health care costs and insuranceMedicarePrescription drugsProduct development and innovation
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 5 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 23, 2021
Referred to the Subcommittee on Health.
Apr 22, 2021
Referred to the Subcommittee on Social Security.
Apr 22, 2021
Referred to the Subcommittee on Health.
Apr 22, 2021
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 22, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 23, 2021

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Bolstering Innovative Options to Save Immediately on Medicines Act or the BIOSIM Act

This bill increases Medicare payments for biosimilars for five years. The bill applies to biosimilars for which the average sales price or wholesale acquisition cost is less than that of the reference biological product, as specified.

 Related & companion bills 3
  • HR 4455 Reintroduction of BIOSIM Act
  • HR 7497 Make Medicine Affordable Act
  • HR 5376 An act to provide for reconciliation pursuant to title II of S. Con. Res. 14.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 5
 Cosponsors 4
All 4 Democratic 1
D
Schrier, Kim
Washington · Jul 22, 2021
Butterfield, G. K.
· Jun 29, 2021
 D
Sherrill, Mikie
New Jersey · Jun 29, 2021
Kinzinger, Adam
· Apr 22, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2815: BIOSIM Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-2815/
MLA
"H.R. 2815: BIOSIM Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-2815/.
Bluebook (legal)
H.R. 2815, 117th Cong. (2026), https://openamerica.io/bill/117-HR-2815/.
Markdown link
[H.R. 2815: BIOSIM Act](https://openamerica.io/bill/117-HR-2815/)
Report a problem